During pregnancy, many parents want reassurance that their baby is developing normally. One commonly recommended screening tool in the second trimester is the quadruple marker test. This blood test helps estimate the risk of certain chromosomal abnormalities and neural tube defects in the fetus. Although it does not provide a definitive diagnosis, the quadruple marker test gives valuable early insight that can guide further evaluation and prenatal care decisions. Because it is noninvasive and widely available, this screening method continues to play an important role in modern prenatal care, especially in settings where advanced genetic testing may not be accessible to everyone.
What Is the Quadruple Marker Test?
The quadruple marker test, often called the quad screen, is a maternal blood screening test performed during the second trimester of pregnancy. It measures the levels of four specific substances in the mother’s blood to estimate the likelihood that the fetus may have certain genetic or structural conditions.
The test is typically done between 15 and 22 weeks of pregnancy, with the most accurate window usually around 16 to 18 weeks. It is important to understand that this is a screening test, not a diagnostic test. This means it assesses risk rather than confirming a condition.
The Four Markers Measured
- Alpha-fetoprotein (AFP)
- Human chorionic gonadotropin (hCG)
- Unconjugated estriol (uE3)
- Inhibin A
By analyzing the pattern of these markers along with maternal factors such as age and gestational age, healthcare providers estimate the risk of certain fetal abnormalities.
Purpose of the Quadruple Marker Test
The primary goal of the quadruple marker test is early risk assessment. It helps identify pregnancies that may benefit from closer monitoring or additional diagnostic testing.
Conditions Screened
- Down syndrome (Trisomy 21)
- Edwards syndrome (Trisomy 18)
- Neural tube defects such as spina bifida
- Abdominal wall defects (in some cases)
Early identification of increased risk allows parents and healthcare providers to plan appropriate follow-up steps.
Understanding Each Marker
Each of the four substances measured in the quad screen provides different information about fetal development. The interpretation depends on the combined pattern rather than any single value.
Alpha-Fetoprotein (AFP)
AFP is a protein produced mainly by the fetal liver. It normally passes into the mother’s bloodstream in small amounts.
High AFP levels may be associated with
- Open neural tube defects
- Abdominal wall defects
- Incorrect gestational dating
- Multiple pregnancy
Low AFP levels can sometimes be linked to chromosomal abnormalities such as Down syndrome.
Human Chorionic Gonadotropin (hCG)
hCG is a hormone produced by the placenta. In the quad screen, elevated hCG levels combined with other marker patterns may indicate an increased risk of Down syndrome.
Unconjugated Estriol (uE3)
uE3 is a form of estrogen produced by both the fetus and the placenta. Low levels may be associated with certain chromosomal abnormalities.
Inhibin A
Inhibin A is a hormone produced by the placenta. Higher-than-normal levels are often associated with an increased risk of Down syndrome when combined with other abnormal marker values.
When Is the Test Recommended?
The quadruple marker test is usually offered as part of routine second-trimester prenatal screening. It may be especially recommended in certain situations.
Common Indications
- Maternal age 35 years or older
- Family history of genetic disorders
- Previous pregnancy with chromosomal abnormality
- Abnormal first-trimester screening
- Limited access to early screening tests
However, many healthcare providers offer the quad screen to all pregnant individuals as part of standard prenatal care.
How the Quadruple Marker Test Is Performed
The procedure itself is simple and similar to a routine blood test.
Step-by-Step Process
- A blood sample is drawn from the mother’s arm.
- The laboratory measures the four marker levels.
- Results are combined with maternal age, weight, and gestational age.
- A risk estimate is calculated.
No fasting or special preparation is usually required.
Interpreting Quad Screen Results
Results from the quadruple marker test are reported as risk estimates rather than positive or negative diagnoses. Understanding this distinction is essential.
Low-Risk Result
A low-risk result means the chance of the screened conditions is below the laboratory cutoff. Most pregnancies fall into this category.
High-Risk Result
A high-risk result indicates an increased probability of certain conditions. It does not mean the baby definitely has a problem. Many high-risk screens are false positives.
Next Steps After High Risk
- Detailed ultrasound examination
- Noninvasive prenatal testing (NIPT)
- Amniocentesis for definitive diagnosis
- Genetic counseling
Further testing helps clarify the actual situation.
Accuracy and Limitations
While the quadruple marker test is useful, it has important limitations.
Detection Rates
The quad screen can detect many cases of Down syndrome, but it is less accurate than newer screening methods such as NIPT. Detection rates vary depending on maternal age and laboratory methods.
False Positives
Some pregnancies flagged as high risk turn out to be completely normal. Incorrect gestational dating is one common reason for misleading results.
Not Diagnostic
The test cannot confirm or rule out conditions with certainty. Only diagnostic procedures like amniocentesis can provide definitive answers.
Advantages of the Quadruple Marker Test
Despite newer technologies, the quad screen remains widely used because of several benefits.
- Noninvasive and safe
- Relatively affordable
- Widely available
- Provides early risk assessment
- Helps guide further testing decisions
In many healthcare systems, it remains an important second-trimester screening option.
Factors That Can Affect Results
Several maternal and pregnancy factors can influence marker levels and risk calculations.
- Incorrect gestational age
- Multiple pregnancy (twins or more)
- Maternal weight and diabetes
- Smoking status
- Placental variations
Accurate pregnancy dating by ultrasound significantly improves test reliability.
Quadruple Test vs Other Prenatal Screening Methods
Today, several prenatal screening options are available. Each has its own advantages.
First-Trimester Combined Screening
This earlier test combines ultrasound and blood markers but must be done in the first trimester.
Noninvasive Prenatal Testing (NIPT)
NIPT analyzes fetal DNA in maternal blood and generally has higher accuracy for chromosomal abnormalities. However, it may be more expensive and less accessible in some regions.
Amniocentesis
This is a diagnostic test rather than a screening test. It provides definitive results but is invasive and carries a small risk of complications.
The quadruple marker test remains an important tool in second-trimester prenatal screening. By measuring four key substances in maternal blood, it helps estimate the risk of chromosomal abnormalities and neural tube defects. Although it cannot provide a definitive diagnosis, the quad screen offers valuable early information that supports informed decision-making during pregnancy. Understanding its purpose, timing, benefits, and limitations allows expectant parents and healthcare providers to use the test appropriately. When combined with ultrasound and follow-up testing when needed, the quadruple marker test continues to play a meaningful role in modern prenatal care.